FDA clears Bayer’s Gadavist as first contrast agent for cardiac MRIBayer’s Gadavist has become the first imaging agent approved in the US to detect blockages in the hearts Share XFDA clears Bayer’s Gadavist as first contrast agent for cardiac MRIhttps://pharmaphorum.com/news/fda-clears-bayers-gadavist-as-first-contrast-agent-for-cardiac-mri/
Digital Health Round-up – Siemens and Biogen take on MS imagingA round-up of this week’s digital healthcare news. Marco Ricci reports. Share XDigital Health Round-up – Siemens and Biogen take on MS imaginghttps://pharmaphorum.com/views-and-analysis/digital-health-round-siemens-biogen-take-ms-imaging/